DEF 14AThe Ballot
Aclaris Therapeutics, Inc. files DEF 14A
Filed Apr 20, 2023 · 3y ago · Accession 0001558370-23-006263
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- DEF 14A
- Filing date
- Apr 20, 2023
- Report date
- —
- Document
- acrs-20230601xdef14a.htm
- Size
- 2.9 MB